Understanding how cannabis legalization affects teen cannabis use and health issues
Assessing the Impact of Cannabis Legalization on Adolescent Cannabis Use and Cannabis-Related Health Conditions
This study looks at how legalizing recreational cannabis affects young people aged 12 to 20, focusing on their cannabis use and health, by analyzing data from nearly a million teens in Northern California.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11034142 on NIH RePORTER |
What this research studies
This research investigates the impact of recreational cannabis legalization on cannabis use and related health conditions among adolescents aged 12 to 20. By analyzing data from nearly 1 million adolescents in Kaiser Permanente Northern California, the study aims to determine how legalization and local regulations influence cannabis use patterns and health outcomes. The research employs a quasi-experimental design to assess changes in cannabis use, cannabis-related health issues, and healthcare utilization following legalization. It also explores the effects of local cannabis policies on these outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who are part of the Kaiser Permanente Northern California healthcare system.
Not a fit: Patients outside the age range of 12 to 20 or those not enrolled in the Kaiser Permanente Northern California system may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide valuable insights into the health implications of cannabis legalization for adolescents, potentially guiding public health policies.
How similar studies have performed: Previous research has indicated that cannabis legalization can impact usage patterns and health outcomes, suggesting that this study's approach is relevant and timely.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Young-Wolff, Kelly Corinne — Kaiser Foundation Research Institute
- Study coordinator: Young-Wolff, Kelly Corinne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.